Fast, flexible model build for effective pharmaceutical forecasting​

Accelerating forecast model build
using J+D specific technology

J+D understand the importance of accurate forecasting in the pharmaceutical and biotechnology industry, and we’ve mastered the art of model building to support this. Forecast models are required to be as unique as the brands and products they support, and we’ve developed the tools to make this possible. Our expertise over the past two decades has been honed to bring clients the most efficient, cost-effective, and flexible solutions, and our focus is clear: delivering exceptional forecasting tools and analytics that meet the unique needs of your brand.

Customized Models in
Days with Aurora

Our proprietary software, Aurora, is at the heart of our models, and the key to fast and tailored forecast model development. We know that time-to-market is crucial, and that’s why we’ve streamlined our model-building process. What used to take weeks can now be accomplished in days, meaning you’ll have your forecasting solution sooner. Especially important when the clock is ticking toward a new product launch.

Utilizing Aurora also empowers us to create tailored forecast models that are specific to your unique requirements. Whether you’re dealing with different disease areas, product lifecycle stages, or organizational processes, Aurora can accommodate it all. This customization ensures that the forecasting models you use are finely tuned to your needs. Additionally, models remain easy to maintain and update and can quickly be adapted to changing demands.

Excel as The Preferred
Tool for Forecasters

We recognize that familiarity and flexibility support better forecasting. That’s why we keep Excel at the core of our solutions. Excel is the preferred tool for forecasters for good reasons. It can adapt to different methodologies and model structures, ensuring that your forecasts are tailored to your specific requirements. While some vendors steer you away from Excel, we stand by it as the right tool. Why? Because it empowers you with flexibility, making forecasting a bespoke process, not one-size-fits-all.

“My colleagues and I love the J+D models in terms of usability and aesthetic appeal. The models include everything the team need to accurately forecast current and future product launches.”

Senior Business Analyst, Big Pharma

“My colleagues and I love the J+D models in terms of usability and aesthetic appeal. The models include everything the team need to accurately forecast current and future product launches.”

Senior Business Analyst, Big Pharma

Cost Effective, Fast Delivery,
and Cloud Compatibility

Our primary focus is on delivering budget-friendly solutions with fast deployment. By leveraging our extensive experience, we are developing models with up to 60% reduced upfront costs. This makes high-quality forecasting more attainable for pharmaceutical companies of all sizes, breaking down budgetary barriers.

Cloud compatibility is another benefit of choosing J+D solutions. Whether you’re using an Aurora built model or other bespoke solution, you can seamlessly integrate them with existing applications, including our FC365 platform. This means that your forecasting and analytics tools are always accessible and up-to-date, ready to guide your decision-making.

“The fast build means the new extension line can now be modeled in detail and be easily explored and provide insightful consolidation and comparison of affiliate forecasts. All this was ready for our next LRP cycle.”

Global Senior Brand Leader Rare Diseases, Big Pharma

“The fast build means the new extension line can now be modeled in detail and be easily explored and provide insightful consolidation and comparison of affiliate forecasts. All this was ready for our next LRP cycle.”

Global Senior Brand Leader Rare Diseases, Big Pharma

To Conclude

Our commitment to Excel, plus Aurora model-build software and SaaS platform solutions, while keeping costs low and speed of delivery high, all set us apart as the go-to partner for forecasting excellence in the pharmaceutical industry.

Get in touch to see how we can help solve your challenges.

Speak with an expert.

more insights

Our Pharmaceutical Forecasting Predictions for 2024

As the pharmaceutical industry contends with growing financial pressures, we examine its strategic outlook for 2024. How does the sector intend to align with projected commercial objectives while continuing to meet patient needs and what are the implications for forecasting teams?

Read more >